Zafirlukast is contraindicated in people by using a record of hypersensitivity reactions to the active drug component along with the inactive compounds within the formulation, such as povidone, lactose, titanium dioxide, or cellulose. In people, zafirlukast inhibited bronchoconstriction attributa